<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Westminster_UK_Test skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Westminster UK/Test</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="overlay-navigation"><NAV role="navigation"><UL><LI><A href="#" data-content="The beginning">Home</A></LI><LI><A href="#" data-content="Curious?">About</A></LI><LI><A href="#" data-content="I got game">Skills</A></LI><LI><A href="#" data-content="Only the finest">Works</A></LI><LI><A href="#" data-content="Don't hesitate">Contact</A></LI></UL></NAV></DIV><SECTION class="home"><A href="https://igem.ml" target="_blank">BioBusters</A></SECTION><DIV class="igem_2017_content_wrapper"><H1>WELCOME TO THE BIO BUSTERS</H1><TITLE> Westminster iGEM </TITLE><DIV class="column full_size"><H1> Abstract </H1><H2>Engineering of N-Acyl Homoserine Lactone (AHL) genes in the quorum-sensing of Pseudomonas</H2><P>Hundreds of millions of patients every year acquire nosocomial infections according to the World Health Organisation. Treatment is complicated by antibiotic resistance with a rapid increase of multi-drug resistance (MDR) bacteria, including strains of the gram-negative genera: Pseudomonas and Escherichia. Opportunistic Pseudomonas are responsible for 10% of all global nosocomial infections in immunocompromised individuals with 50-90% of patients of cystic fibrosis patients suffering from a Pseudomonas Aeruginosa infection.
A major contributor to  antibiotic resistance is  bacterial aggregation to form biofilms. Bacteria within biofilms communicate through chemicals, such as N-Acyl homoserine lactones (AHL), quorum-sensing molecules essential to biofilm formation. We  aim to develop strategies to inhibit biofilm formation by targeting AHL regulation genes: ppuR, ppuA, ppuI and RsaL in Pseudomonas putida. This project has a vast range of potential therapeutic applications such as the development of biocontainment devices and will provide fundamental information to understanding and developing tools in combating antibiotic resistance.
</P></DIV><A href="https://2017.igem.org/Team:Westminster_UK2/Test"><DIV class="submenu_button" id="Test_Meet the team"><P>Meet the Team</P></DIV></A></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>